Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations by Lim, Annette M, PhD, McDowell, Lachlan, FRANZCR, Hurt, Chris, MSc, Le Tourneau, Christophe, Prof, Homma, Akihiro, PhD, Shenouda, George, FRCP, Thomson, David J, Prof, Moya-Plana, Antoine, Prof, Henson, Christina, MD, Szturz, Petr, PhD, Day, Andrew T, MD, Bates, James E, MD, Lazarakis, Smaro, BEd[Sec]-Lib, Thariat, Juliette, Prof, Psyrri, Amanda, Prof, Mehanna, Hisham, Prof, Yom, Sue S, Prof

Get full text

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double... by Lee, Nancy Y, Prof, Ferris, Robert L, Prof, Psyrri, Amanda, MD, Haddad, Robert I, Prof, Tahara, Makoto, MD, Bourhis, Jean, Prof, Harrington, Kevin, Prof, Chang, Peter Mu-Hsin, MD, Lin, Jin-Ching, Prof, Razaq, Mohammad Abdul, MD, Teixeira, Maria Margarida, MD, Lövey, József, MD, Chamois, Jerome, MD, Rueda, Antonio, MD, Hu, Chaosu, Prof, Dunn, Lara A, MD, Dvorkin, Mikhail Vladimirovich, MD, De Beukelaer, Steven, MD, Pavlov, Dmitri, PhD, Thurm, Holger, MD, Cohen, Ezra, Prof

Get full text